Heterogeneity of glycolysis in cancers and therapeutic opportunities

Biochemical Pharmacology

Volumn 92, Issue 1, 2014, Pages 12-21

  Warmoes, Marc O ^a   Locasale, Jason W ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Anti glycolytic agents; Cancer; Glycolysis; Isoenzymes; Spliceforms

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; 6 PHOSPHOFRUCTOKINASE; FRUCTOSE 2,6 BISPHOSPHATASE; GLUCOSE; GLYCOLYTIC ENZYME; HEXOKINASE; PHOSPHOGLYCERATE MUTASE; PYRUVATE KINASE; TUMOR MARKER; BIOLOGICAL MARKER; PHOSPHOTRANSFERASE;

CANCER GENETICS; CANCER THERAPY; DRUG TARGETING; ENZYME KINETICS; ENZYME POLYMORPHISM; ENZYME REGULATION; GENETIC HETEROGENEITY; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; NEOPLASM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; DRUG EFFECTS; ENERGY METABOLISM; GENETICS; METABOLISM; NEOPLASMS; OXYGEN CONSUMPTION; PHYSIOLOGY; UPREGULATION;

BIOMARKERS; ENERGY METABOLISM; GLUCOSE; GLYCOLYSIS; HUMANS; NEOPLASMS; OXYGEN CONSUMPTION; PHOSPHOTRANSFERASES; UP-REGULATION;

EID: 84908208471     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.07.019     Document Type: Review

References (166)

1. S.Y. Lunt, and M.G. Vander Heiden Aerobic glycolysis: meeting the metabolic requirements of cell proliferation Annu Rev Cell Dev Biol 27 2011 441 464
2. J.W. Locasale The consequences of enhanced cell-autonomous glucose metabolism Trends Endocrinol Metabol TEM 23 2012 545 551
3. A.J. Levine, and A.M. Puzio-Kuter The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes Science 330 2010 1340 1344
4. K.M. Bailey, J.W. Wojtkowiak, A.I. Hashim, and R.J. Gillies Targeting the metabolic microenvironment of tumors Adv Pharmacol 65 2012 63 107
5. E.D. Michelakis, G. Sutendra, P. Dromparis, L. Webster, A. Haromy, and E. Niven Metabolic modulation of glioblastoma with dichloroacetate Sci Transl Med 2 2010 31ra4
6. H. Pelicano, D.S. Martin, R.H. Xu, and P. Huang Glycolysis inhibition for anticancer treatment Oncogene 25 2006 4633 4646
7. L. Galluzzi, O. Kepp, M.G. Vander Heiden, and G. Kroemer Metabolic targets for cancer therapy Nature Rev Drug Discov 12 2013 829 846
8. B. Dwarakanath, and V. Jain Targeting glucose metabolism with 2-deoxy-d-glucose for improving cancer therapy Future Oncol 5 2009 581 585
9. G. Maschek, N. Savaraj, W. Priebe, P. Braunschweiger, K. Hamilton, and G.F. Tidmarsh 2-Deoxy-d-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo Cancer Res 64 2004 31 34
10. M. Warmoes, J.E. Jaspers, G. Xu, B.K. Sampadi, T.V. Pham, and J.C. Knol Proteomics of genetically engineered mouse mammary tumors identifies fatty acid metabolism members as potential predictive markers for cisplatin resistance Mol Cell Proteomics: MCP 12 2013 1319 1334
11. J. Xie, B.S. Wang, D.H. Yu, Q. Lu, J. Ma, and H. Qi Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells Int J Oncol 38 2011 409 417
12. J.W. Locasale Serine, glycine and one-carbon units: cancer metabolism in full circle Nature Rev Cancer 13 2013 572 583
13. M.G. Vander Heiden Targeting cancer metabolism: a therapeutic window opens Nature Rev Drug Discov 10 2011 671 684
14. J.R. Doherty, and J.L. Cleveland Targeting lactate metabolism for cancer therapeutics J Clin Investig 123 2013 3685 3692
15. K.A. Webster Evolution of the coordinate regulation of glycolytic enzyme genes by hypoxia J Exp Biol 206 2003 2911 2922
16. M.A. Herman, and B.B. Kahn Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony J Clin Investig 116 2006 1767 1775
17. L. Hue, C. Beauloye, A.S. Marsin, L. Bertrand, S. Horman, and M.H. Rider Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways J Mol Cell Cardiol 34 2002 1091 1097
18. G. Eelen, B. Cruys, J. Welti, K. De Bock, and P. Carmeliet Control of vessel sprouting by genetic and metabolic determinants Trends Endocrinol Metab: TEM 24 2013 589 596
19. E.L. Pearce, M.C. Poffenberger, C.H. Chang, and R.G. Jones Fueling immunity: insights into metabolism and lymphocyte function Science 342 2013 1242454
20. K. Ito, and T. Suda Metabolic requirements for the maintenance of self-renewing stem cells Nature Rev Mol Cell Biol 15 2014 243 256
21. J. Hu, J.W. Locasale, J.H. Bielas, J. O'Sullivan, K. Sheahan, and L.C. Cantley Heterogeneity of tumor-induced gene expression changes in the human metabolic network Nature Biotechnol 31 2013 522 529
22. G. Wang, Z. Xu, C. Wang, F. Yao, J. Li, and C. Chen Differential phosphofructokinase-1 isoenzyme patterns associated with glycolytic efficiency in human breast cancer and paracancer tissues Oncol Lett 6 2013 1701 1706
23. S. Vora, J.P. Halper, and D.M. Knowles Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation- and progression-linked discriminants of malignancy Cancer Res 45 1985 2993 3001
24. S. Marjanovic, S. Skog, T. Heiden, B. Tribukait, and B.D. Nelson Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry Exp Cell Res 193 1991 425 431
25. H. Richard, M.H. Schulz, M. Sultan, A. Nurnberger, S. Schrinner, and D. Balzereit Prediction of alternative isoforms from exon expression levels in RNA-Seq experiments Nucl Acids Res 38 2010 e112
26. C. Johnson, M.O. Warmoes, X. Shen, and J.W. Locasale Epigenetics and cancer metabolism Cancer Lett 2014 [in press]
27. A. Prigione, N. Rohwer, S. Hoffmann, B. Mlody, K. Drews, and R. Bukowiecki HIF1alpha modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2 Stem Cells 32 2014 364 376
28. P.K. Singh, K. Mehla, M.A. Hollingsworth, and K.R. Johnson Regulation of aerobic glycolysis by microRNAs in cancer Mol Cell Pharmacol 3 2011 125 134
29. J.W. Kornfeld, and J.C. Bruning Regulation of metabolism by long, non-coding RNAs Front Genet 5 2014 57
30. M. Chen, J. Zhang, and J.L. Manley Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA Cancer Res 70 2010 8977 8980
31. T. Yamamoto, N. Takano, K. Ishiwata, M. Ohmura, Y. Nagahata, and T. Matsuura Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway Nature Commun 5 2014 3480
32. P.T. Doulias, M. Tenopoulou, J.L. Greene, K. Raju, and H. Ischiropoulos Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation Sci Signal 6 2013 rs1
33. M. Yang, T. Soga, and P.J. Pollard Oncometabolites: linking altered metabolism with cancer J Clin Investig 123 2013 3652 3658
34. C. Peng, Z. Lu, Z. Xie, Z. Cheng, Y. Chen, and M. Tan The first identification of lysine malonylation substrates and its regulatory enzyme Mol Cell Proteomics: MCP 10 2011 M111 012658
35. B.W. Wong, A. Kuchnio, U. Bruning, and P. Carmeliet Emerging novel functions of the oxygen-sensing prolyl hydroxylase domain enzymes Trends Biochem Sci 38 2013 3 11
36. J. Seo, J. Jeong, Y.M. Kim, N. Hwang, E. Paek, and K.J. Lee Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase J Proteome Res 7 2008 587 602
37. A.K. Mustafa, M.M. Gadalla, N. Sen, S. Kim, W. Mu, and S.K. Gazi H2S signals through protein S-sulfhydration Sci Signal 2 2009 ra72
38. J.W. Locasale, and L.C. Cantley Metabolic flux and the regulation of mammalian cell growth Cell Metab 14 2011 443 451
39. C. Slawson, and G.W. Hart O-GlcNAc signalling: implications for cancer cell biology Nature Rev Cancer 11 2011 678 684
40. R.B. Robey, and N. Hay Is Akt the Warburg kinase?-Akt-energy metabolism interactions and oncogenesis Semin Cancer Biol 19 2009 25 31
41. W. Yang, Y. Xia, H. Ji, Y. Zheng, J. Liang, and W. Huang Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation Nature 480 2011 118 122
42. C. Tristan, N. Shahani, T.W. Sedlak, and A. Sawa The diverse functions of GAPDH: views from different subcellular compartments Cell Signal 23 2011 317 323
43. A. Tarze, A. Deniaud, M. Le Bras, E. Maillier, D. Molle, and N. Larochette GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization Oncogene 26 2007 2606 2620
44. P.V. Hornbeck, J.M. Kornhauser, S. Tkachev, B. Zhang, E. Skrzypek, and B. Murray PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse Nucl Acids Res 40 2012 D261 D270
45. A.P. Oliveira, and U. Sauer The importance of post-translational modifications in regulating Saccharomyces cerevisiae metabolism FEMS Yeast Res 12 2012 104 117
46. B.J. Quinn, H. Kitagawa, R.M. Memmott, J.J. Gills, and P.A. Dennis Repositioning metformin for cancer prevention and treatment Trends Endocrinol Metab: TEM 24 2013 469 480
47. S. Niraula, R.J. Dowling, M. Ennis, M.C. Chang, S.J. Done, and N. Hood Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study Breast Cancer Res Treat 135 2012 821 830
48. S. Del Barco, A. Vazquez-Martin, S. Cufi, C. Oliveras-Ferraros, J. Bosch-Barrera, and J. Joven Metformin: multi-faceted protection against cancer Oncotarget 2 2011 896 917
49. M. Schmidt, N. Pfetzer, M. Schwab, I. Strauss, and U. Kammerer Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: a pilot trial Nutr Metab 8 2011 54
50. B.G. Allen, S.K. Bhatia, J.M. Buatti, K.E. Brandt, K.E. Lindholm, and A.M. Button Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts Clin Cancer Res Off J Am Assoc Cancer Res 19 2013 3905 3913
51. V.W. Ho, K. Leung, A. Hsu, B. Luk, J. Lai, and S.Y. Shen A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation Cancer Res 71 2011 4484 4493
52. C.V. Dang Links between metabolism and cancer Genes Dev 26 2012 877 890
53. A.M. Thompson Molecular pathways: preclinical models and clinical trials with metformin in breast cancer Clin Cancer Res Off J Am Assoc Cancer Res 20 2014 2508 2515
54. E.C. Woolf, and A.C. Scheck The ketogenic diet for the treatment of malignant glioma J Lipid Res 2014 Epub ahead of print
55. M. Franciosi, G. Lucisano, E. Lapice, G.F. Strippoli, F. Pellegrini, and A. Nicolucci Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review PLoS One 8 2013 e71583
56. Y. Zhao, E.B. Butler, and M. Tan Targeting cellular metabolism to improve cancer therapeutics Cell Death Dis 4 2013 e532
57. R. Moreno-Sanchez, E. Saavedra, S. Rodriguez-Enriquez, J.C. Gallardo-Perez, H. Quezada, and H.V. Westerhoff Metabolic control analysis indicates a change of strategy in the treatment of cancer Mitochondrion 10 2010 626 639
58. J.J. Lu, W. Pan, Y.J. Hu, and Y.T. Wang Multi-target drugs: the trend of drug research and development PLoS One 7 2012 e40262
59. A. Kamb, S. Wee, and C. Lengauer Why is cancer drug discovery so difficult Nature Rev Drug Discov 6 2007 115 120
60. L. Xie, L. Xie, and P.E. Bourne Structure-based systems biology for analyzing off-target binding Curr Opin Struct Biol 21 2011 189 199
61. Y.H. Ko, B.L. Smith, Y. Wang, M.G. Pomper, D.A. Rini, and M.S. Torbenson Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP Biochem Biophys Res Commun 324 2004 269 275
62. M.C. Shoshan 3-Bromopyruvate: targets and outcomes J Bioenerg Biomembr 44 2012 7 15
63. L. Gong, Y. Wei, X. Yu, J. Peng, and X. Leng 3-Bromopyruvic acid, a hexokinase II inhibitor, is an effective antitumor agent on the hepatoma cells: in vitro and in vivo findings Anti-cancer Agents Med Chem 14 2014 771 776
64. J. Yun, C. Rago, I. Cheong, R. Pagliarini, P. Angenendt, and H. Rajagopalan Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells Science 325 2009 1555 1559
65. K. Birsoy, T. Wang, R. Possemato, O.H. Yilmaz, C.E. Koch, and W.W. Chen MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors Nature Genet 45 2013 104 108
66. M.S. Ricci, and W.X. Zong Chemotherapeutic approaches for targeting cell death pathways Oncologist 11 2006 342 357
67. D.B. Longley, D.P. Harkin, and P.G. Johnston 5-Fluorouracil: mechanisms of action and clinical strategies Nature Rev Cancer 3 2003 330 338
68. M. Abal, J.M. Andreu, and I. Barasoain Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action Curr Cancer Drug Targets 3 2003 193 203
69. D. Fu, J.A. Calvo, and L.D. Samson Balancing repair and tolerance of DNA damage caused by alkylating agents Nature Rev Cancer 12 2012 104 120
70. J.L. Nitiss Targeting DNA topoisomerase II in cancer chemotherapy Nature Rev Cancer 9 2009 338 350
71. B.A. Chabner, and T.G. Roberts Jr. Timeline: chemotherapy and the war on cancer Nature Rev Cancer 5 2005 65 72
72. M.F. Sorrentino, J. Kim, A.E. Foderaro, and A.G. Truesdell 5-fluorouracil induced cardiotoxicity: review of the literature Cardiol J 19 2012 453 458
73. K.L. Hennenfent, and R. Govindan Novel formulations of taxanes: a review. Old wine in a new bottle? Ann Oncol Off J Eur Soc Med Oncol/ESMO 17 2006 735 749
74. G. Curigliano, D. Cardinale, T. Suter, G. Plataniotis, E. de Azambuja, and M.T. Sandri Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines Ann Oncol Off J Eur Soc Med Oncol/ESMO 23 Suppl 7: 2012 vii155-66
75. C.J. De Saedeleer, P.E. Porporato, T. Copetti, J. Perez-Escuredo, V.L. Payen, and L. Brisson Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration Oncogene 2013 [Epub ahead of print]
76. P. Sonveaux, F. Vegran, T. Schroeder, M.C. Wergin, J. Verrax, and Z.N. Rabbani Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice J Clin Investig 118 2008 3930 3942
77. C. Granchi, and F. Minutolo Anticancer agents that counteract tumor glycolysis ChemMedChem 7 2012 1318 1350
78. K.C. Patra, and N. Hay Hexokinase 2 as oncotarget Oncotarget 4 2013 1862 1863
79. K.C. Patra, Q. Wang, P.T. Bhaskar, L. Miller, Z. Wang, and W. Wheaton Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer Cancer Cell 24 2013 213 228
80. S.P. Mathupala, A. Rempel, and P.L. Pedersen Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions J Biol Chem 276 2001 43407 43412
81. J.E. Wilson Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function J Exp Biol 206 2003 2049 2057
82. M. Kurtoglu, J.C. Maher, and T.J. Lampidis Differential toxic mechanisms of 2-deoxy-d-glucose versus 2-fluorodeoxy-d-glucose in hypoxic and normoxic tumor cells Antioxid Redox Signal 9 2007 1383 1390
83. R.K. Crane, and A. Sols The non-competitive inhibition of brain hexokinase by glucose-6-phosphate and related compounds J Biol Chem 210 1954 597 606
84. G.E. Staal, A. Kalff, E.C. Heesbeen, C.W. van Veelen, and G. Rijksen Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas Cancer Res 47 1987 5047 5051
85. G.A. Dunaway A review of animal phosphofructokinase isozymes with an emphasis on their physiological role Mol Cell Biochem 52 1983 75 91
86. I. Mor, E.C. Cheung, and K.H. Vousden Control of glycolysis through regulation of PFK1: old friends and recent additions Cold Spring Harbor Symposia Quant Biol 76 2011 211 216
87. A. Yalcin, S. Telang, B. Clem, and J. Chesney Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer Exp Mol Pathol 86 2009 174 179
88. S.L. Abrahams, and E.S. Younathan Modulation of the kinetic properties of phosphofructokinase by ammonium ions J Biol Chem 246 1971 2464 2467
89. H. Eagle Nutrition needs of mammalian cells in tissue culture Science 122 1955 501 514
90. M. Sola-Penna, D. Da Silva, W.S. Coelho, M.M. Marinho-Carvalho, and P. Zancan Regulation of mammalian muscle type 6-phosphofructo-1-kinase and its implication for the control of the metabolism IUBMB Life 62 2010 791 796
91. S. Ros, and A. Schulze Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism Cancer Metab 1 2013 8
92. O. Minchenko, I. Opentanova, and J. Caro Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo FEBS Lett 554 2003 264 270
93. B.F. Clem, J. O'Neal, G. Tapolsky, A.L. Clem, Y. Imbert-Fernandez, and D.A. Kerr 2nd Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer Mol Cancer Therap 12 2013 1461 1470
94. B. Clem, S. Telang, A. Clem, A. Yalcin, J. Meier, and A. Simmons Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth Mol Cancer Therap 7 2008 110 120
95. S. Schoors, A.R. Cantelmo, M. Georgiadou, P. Stapor, X. Wang, and A. Quaegebeur Incomplete and transitory decrease of glycolysis: a new paradigm for anti-angiogenic therapy Cell Cycle 13 2014 16 22
96. S. Schoors, K. De Bock, A.R. Cantelmo, M. Georgiadou, B. Ghesquiere, and S. Cauwenberghs Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis Cell Metab 19 2014 37 48
97. K. De Bock, M. Georgiadou, and P. Carmeliet Role of endothelial cell metabolism in vessel sprouting Cell Metab 18 2013 634 647
98. G. Rehman, A. Shehzad, A.L. Khan, and M. Hamayun Role of AMP-activated protein kinase in cancer therapy Archiv der Pharm 347 2014 457 468
99. Z. Luo, M. Zang, and W. Guo AMPK as a metabolic tumor suppressor: control of metabolism and cell growth Future Oncol 6 2010 457 470
100. N. Okamura, and R. Sakakibara A common phosphorylation site for cyclic AMP-dependent protein kinase and protein kinase C in human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase Biosci Biotechnol Biochem 62 1998 2039 2042
101. V. Egler, S. Korur, M. Failly, J.L. Boulay, R. Imber, and M.M. Lino Histone deacetylase inhibition and blockade of the glycolytic pathway synergistically induce glioblastoma cell death Clin Cancer Res Off J Am Assoc Cancer Res 14 2008 3132 3140
102. N.P. Manes, and M.R. El-Maghrabi The kinase activity of human brain 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is regulated via inhibition by phosphoenolpyruvate Arch Biochem Biophys 438 2005 125 136
103. N. Majewski, V. Nogueira, P. Bhaskar, P.E. Coy, J.E. Skeen, and K. Gottlob Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak Mol Cell 16 2004 819 830
104. A. Bellacosa, C.C. Kumar, A. Di Cristofano, and J.R. Testa Activation of AKT kinases in cancer: implications for therapeutic targeting Adv Cancer Res 94 2005 29 86
105. W. Yi, P.M. Clark, D.E. Mason, M.C. Keenan, C. Hill, and W.A. Goddard 3rd Phosphofructokinase 1 glycosylation regulates cell growth and metabolism Science 337 2012 975 980
106. A. Smerc, E. Sodja, and M. Legisa Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism PLoS One 6 2011 e19645
107. J.V. Olsen, M. Vermeulen, A. Santamaria, C. Kumar, M.L. Miller, and L.J. Jensen Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis Sci Signal 3 2010 ra3
108. G.W. Hart, C. Slawson, G. Ramirez-Correa, and O. Lagerlof Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease Annu Rev Biochem 80 2011 825 858
109. C.M. Ferrer, T.P. Lynch, V.L. Sodi, J.N. Falcone, L.P. Schwab, and D.L. Peacock O-GlcNacylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway Mol Cell 2014 Epub
110. M.G. Vander Heiden, J.W. Locasale, K.D. Swanson, H. Sharfi, G.J. Heffron, and D. Amador-Noguez Evidence for an alternative glycolytic pathway in rapidly proliferating cells Science 329 2010 1492 1499
111. W.C. Hallows, W. Yu, and J.M. Denu Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation J Biol Chem 287 2012 3850 3858
112. T. Hitosugi, L. Zhou, J. Fan, S. Elf, L. Zhang, and J. Xie Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation Nature Commun 4 2013 1790
113. T. Hitosugi, L. Zhou, S. Elf, J. Fan, H.B. Kang, and J.H. Seo Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth Cancer Cell 22 2012 585 600
114. B. Chaneton, and E. Gottlieb Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer Trends Biochem Sci 37 2012 309 316
115. B.C. Mulukutla, S. Khan, A. Lange, and W.S. Hu Glucose metabolism in mammalian cell culture: new insights for tweaking vintage pathways Trends Biotechnol 28 2010 476 484
116. B. Chaneton, P. Hillmann, L. Zheng, A.C. Martin, O.D. Maddocks, and A. Chokkathukalam Serine is a natural ligand and allosteric activator of pyruvate kinase M2 Nature 491 2012 458 462
117. K.E. Keller, Z.M. Doctor, Z.W. Dwyer, and Y.S. Lee SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells Mol Cell 53 2014 700 709
118. M. Cortes-Cros, C. Hemmerlin, S. Ferretti, J. Zhang, J.S. Gounarides, and H. Yin M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth Proc Natl Acad Sci USA 110 2013 489 494
119. W.J. Israelsen, T.L. Dayton, S.M. Davidson, B.P. Fiske, A.M. Hosios, and G. Bellinger PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells Cell 155 2013 397 409
120. D. Anastasiou, Y. Yu, W.J. Israelsen, J.K. Jiang, M.B. Boxer, and B.S. Hong Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis Nature Chem Biol 8 2012 839 847
121. R.E. Moellering, and B.F. Cravatt Functional lysine modification by an intrinsically reactive primary glycolytic metabolite Science 341 2013 549 553
122. R. Aebersold, A.L. Burlingame, and R.A. Bradshaw Western blots versus selected reaction monitoring assays: time to turn the tables? Mol Cell Proteomics: MCP 12 2013 2381 2382
123. G. Panasyuk, C. Espeillac, C. Chauvin, L.A. Pradelli, Y. Horie, and A. Suzuki PPARgamma contributes to PKM2 and HK2 expression in fatty liver Nature Commun 3 2012 672
124. J.A. Martin, and Z. Wang Next-generation transcriptome assembly Nature Rev Genet 12 2011 671 682
125. W. Zhou, L.A. Liotta, and E.F. Petricoin Cancer metabolism: what we can learn from proteomic analysis by mass spectrometry Cancer Genom Proteom 9 2012 373 381
126. B.H. ter Kuile, and H.V. Westerhoff Transcriptome meets metabolome: hierarchical and metabolic regulation of the glycolytic pathway FEBS Lett 500 2001 169 171
127. J.L. Griffin, and J.P. Shockcor Metabolic profiles of cancer cells Nature Rev Cancer 4 2004 551 561
128. L.F. de Geus-Oei, D. Vriens, H.W. van Laarhoven, W.T. van der Graaf, and W.J. Oyen Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review, Journal of nuclear medicine: official publication Soc Nucl Med 50 Suppl 1 2009 43S 54S
129. C. Plathow, and W.A. Weber Tumor cell metabolism imaging, Journal of nuclear medicine: official publication Soc Nucl Med 49 Suppl 2 2008 43S 63S
130. J. Kurhanewicz, D.B. Vigneron, K. Brindle, E.Y. Chekmenev, A. Comment, and C.H. Cunningham Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research Neoplasia 13 2011 81 97
131. E.G. Armitage, and C. Barbas Metabolomics in cancer biomarker discovery: current trends and future perspectives J Pharm Biomed Anal 87 2014 1 11
132. B.C. Mulukutla, A. Yongky, P. Daoutidis, and W.S. Hu Bistability in glycolysis pathway as a physiological switch in energy metabolism PLoS One 9 2014 e98756
133. A. Marin-Hernandez, J.C. Gallardo-Perez, S.J. Ralph, S. Rodriguez-Enriquez, and R. Moreno-Sanchez HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms Mini Rev Med Chem 9 2009 1084 1101
134. L. Alberghina, and H.V. Westerhoff Syst Biol: Defin Perspect 13 2005 1 408
135. H. Link, D. Christodoulou, and U. Sauer Advancing metabolic models with kinetic information Curr Opin Biotechnol 29C 2014 8 14
136. C.S. Duckwall, T.A. Murphy, and J.D. Young Mapping cancer cell metabolism with (13)C flux analysis: recent progress and future challenges J Carcinogenesis 12 2013 13
137. R.D. Beger A review of applications of metabolomics in cancer Metabolites 3 2013 552 574
138. S. Wei, L. Liu, J. Zhang, J. Bowers, G.A. Gowda, and H. Seeger Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer Mol Oncol 7 2013 297 307
139. Y. Hou, M. Yin, F. Sun, T. Zhang, X. Zhou, and H. Li A metabolomics approach for predicting the response to neoadjuvant chemotherapy in cervical cancer patients Mol Bioyst 10 2014 2126 2133
140. J.L. Spratlin, N.J. Serkova, and S.G. Eckhardt Clinical applications of metabolomics in oncology: a review Clin Cancer Res Off J Am Assoc Cancer Res 15 2009 431 440
141. J. Xie, H. Wu, C. Dai, Q. Pan, Z. Ding, and D. Hu Beyond Warburg effect - dual metabolic nature of cancer cells Sci Rep 4 2014 4927
142. M.A. Iqbal, F.A. Siddiqui, V. Gupta, S. Chattopadhyay, P. Gopinath, and B. Kumar Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2 Mol Cancer 12 2013 72
143. R.N. Gacche, and R.J. Meshram Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth Prog Biophys Mol Biol 113 2013 333 354
144. K. De Bock, M. Mazzone, and P. Carmeliet Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not Nature Rev Clin Oncol 8 2011 393 404
145. A. Rapisarda, and G. Melillo Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia Nature Rev Clin Oncol 9 2012 378 390
146. W.R. Wilson, and M.P. Hay Targeting hypoxia in cancer therapy Nature Rev Cancer 11 2011 393 410
147. C.H. Chang, J.D. Curtis, L.B. Maggi Jr.; B. Faubert, A.V. Villarino, and D. O'Sullivan Posttranscriptional control of T cell effector function by aerobic glycolysis Cell 153 2013 1239 1251
148. H. Dong, and T.N. Bullock Metabolic influences that regulate dendritic cell function in tumors Front Immunol 5 2014 24
149. C. Carmona-Fontaine, V. Bucci, L. Akkari, M. Deforet, J.A. Joyce, and J.B. Xavier Emergence of spatial structure in the tumor microenvironment due to the Warburg effect Proc Natl Acad Sci USA 110 2013 19402 19407
150. H.M. Werner, G.B. Mills, and P.T. Ram Cancer systems biology: a peek into the future of patient care Nature Rev Clin Oncol 11 2014 167 176
151. C. UniProt Activities at the universal protein resource (UniProt) Nucleic Acids Res 42 2014 D191 D198
152. E.W. Sayers, T. Barrett, D.A. Benson, S.H. Bryant, K. Canese, and V. Chetvernin Database resources of the National Center for Biotechnology Information Nucleic Acids Res 37 2009 D5 D15
153. M.L. Massa, J.J. Gagliardino, and F. Francini Liver glucokinase: an overview on the regulatory mechanisms of its activity IUBMB Life 63 2011 1 6
154. K.J. Ahn, J. Kim, M. Yun, J.H. Park, and J.D. Lee Enzymatic properties of the N- and C-terminal halves of human hexokinase II BMB Rep 42 2009 350 355
155. A. Marin-Hernandez, J.C. Gallardo-Perez, S. Rodriguez-Enriquez, R. Encalada, R. Moreno-Sanchez, and E. Saavedra Modeling cancer glycolysis Biochim Biophys Acta 1807 2011 755 767
156. R. Sakakibara, M. Kato, N. Okamura, T. Nakagawa, Y. Komada, and N. Tominaga Characterization of a human placental fructose-6-phosphate, 2-kinase/fructose-2,6-bisphosphatase J Biochem 122 1997 122 128
157. T.L. Arakaki, J.A. Pezza, M.A. Cronin, C.E. Hopkins, D.B. Zimmer, and D.R. Tolan Structure of human brain fructose 1,6-(bis)phosphate aldolase: linking isozyme structure with function Protein Sci Publ Protein Soc 13 2004 3077 3084
158. P.A. Eagles, and M. Iqbal A comparative study of aldolase from human muscle and liver Biochem J 133 1973 429 439
159. A. Shimizu, F. Suzuki, and K. Kato Characterization of alpha alpha, beta beta, gamma gamma and alpha gamma human enolase isozymes, and preparation of hybrid enolases (alpha gamma, beta gamma and alpha beta) from homodimeric forms Biochim Biophys Acta 748 1983 278 284
160. P. Rodriguez-Horche, J. Luque, E. Perez-Artes, M. Pineda, and M. Pinilla Comparative kinetic behaviour and regulation by fructose-1,6-bisphosphate and ATP of pyruvate kinase from erythrocytes, reticulocytes and bone marrow cells Comp Biochem Physiol B, Comp Biochem 87 1987 553 557
161. S. Mazurek Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells Int J Biochem Cell Biol 43 2011 969 980
162. M.H. Rider, L. Bertrand, D. Vertommen, P.A. Michels, G.G. Rousseau, and L. Hue 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis Biochem J 381 2004 561 579
163. Y.Y. Shchutskaya, Y.L. Elkina, M.L. Kuravsky, E.E. Bragina, and E.V. Schmalhausen Investigation of glyceraldehyde-3-phosphate dehydrogenase from human sperms Biochem Biokhim 73 2008 185 191
164. H. Qiu, S. Zhao, X. Xu, M. Yerle, and B. Liu Assignment and expression patterns of porcine muscle-specific isoform of phosphoglycerate mutase gene J Genet Genom 35 2008 257 260
165. M. Capello, S. Ferri-Borgogno, P. Cappello, and F. Novelli alpha-Enolase: a promising therapeutic and diagnostic tumor target FEBS J 278 2011 1064 1074
166. M.A. Soh, S.H. Garrett, S. Somji, J.R. Dunlevy, X.D. Zhou, and M.A. Sens Arsenic, cadmium and neuron specific enolase (ENO2, gamma-enolase) expression in breast cancer Cancer Cell Int 11 2011 41